Superstring Capital Management’s Travere Therapeutics TVTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$4.09M	Buy	276,474 +38,987	+16%	+$577K	4.84%	9
2025 Q1	$4.26M	Buy	+237,487	New	+$4.26M	5.06%	9